Treatment for Acute Myelogenous Leukemia by Low Dose Irradiation Based Conditioning and Hematopoietic Cell Transplantation from Related and Unrelated Donors.
Dietger Niederwieser(Leipzig University of Applied Sciences), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ed Agura, Monic J. Stuart(United States Department of Veterans Affairs), Catherine Cordonnier(Université Paris-Est Créteil), Wolfram Pönisch(United States Department of Veterans Affairs), Thomas R. Chauncey(City Of Hope National Medical Center), Thoralf Lange, Barry E. Storer(City Of Hope National Medical Center), Aloïs Gratwohl, Leante Grommisch, Ute Hegenbart(Heidelberg University), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Bernard Rio(Hotel Dieu Hospital), Karl G. Blume(City Of Hope National Medical Center), David G. Maloney(Fred Hutch Cancer Center), Michael B. Maris(Colorado Blood Cancer Institute), Hildegard Greinix(Medical University of Graz)
Cited by 6
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k